STOCK TITAN

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Penumbra, Inc. (NYSE: PEN) will host a conference call to discuss first quarter 2024 financial results on May 7, 2024. The call will be at 4:30 PM Eastern Time. Investors can access the call via phone or webcast on the company's website.
Positive
  • None.
Negative
  • None.

ALAMEDA, Calif., April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024 at 4:30 PM Eastern Time. A press release with first quarter 2024 financial results will be issued after market close that day.

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 7567226), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations

Penumbra, Inc.
510-995-2461
investors@penumbrainc.com 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-first-quarter-2024-earnings-release-and-conference-call-for-may-7-2024-302108911.html

SOURCE Penumbra, Inc.

Penumbra, Inc. will host the conference call on May 7, 2024.

The conference call will be at 4:30 PM Eastern Time.

Investors can access the call by dialing (888) 596-4144 (conference id: 7567226) or via webcast on the company's website.

The webcast will be available for at least two weeks following the completion of the call on the company's website.
Penumbra, Inc.

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Stock Data

7.83B
37.19M
3.82%
89.81%
4.98%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ALAMEDA

About PEN

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.